Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Reilly

Showing results (631-640 of 929) with videos related to

Pageof 93
Sort By:
International Journal of Toxicology|October 8, 2013
Nonclinical toxicology assessments support the chronic safety of dapagliflozin, a first-in-class sodium-glucose cotransporter 2 inhibitorMark Tirmenstein, Thomas E Dorr, Evan B Janovitz, et al.
Circulation|June 3, 1997
8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivoN Delanty, M P Reilly, D Pratico, et al.
Fertility and Sterility|March 16, 2010
Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trialShrita M Patel, Nayyar Iqbal, Shailja Kaul, et al.
Transfusion|July 1, 1997
The presurgical management with erythrocytapheresis of a patient with a high-oxygen-affinity, unstable Hb variant (Hb Bryn Mawr)P J Larson, D F Friedman, M P Reilly, et al.
Clinical Endocrinology|August 20, 2008
Resistin gene variation is associated with systemic inflammation but not plasma adipokine levels, metabolic syndrome or coronary atherosclerosis in nondiabetic CaucasiansAtif N Qasim, Thomas S Metkus, Mahlet Tadesse, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 30, 2014
Carcinogenicity risk assessment supports the chronic safety of dapagliflozin, an inhibitor of sodium-glucose co-transporter 2, in the treatment of type 2 diabetes mellitusTimothy P Reilly, Michael J Graziano, Evan B Janovitz, et al.
Clinical Endocrinology|September 30, 2010
Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetesAtif N Qasim, Venkata Budharaju, Nehal N Mehta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse modelS E McKenzie, S M Taylor, P Malladi, et al.
Ochsner Journal|September 24, 2016
Using the Minimally Invasive Impella 5.0 via the Right Subclavian Artery Cutdown for Acute on Chronic Decompensated Heart Failure as a Bridge to DecisionAditya Bansal, Jay K Bhama, Rajan Patel, et al.
Diabetes|November 14, 2013
Occurrence of spontaneous pancreatic lesions in normal and diabetic rats: a potential confounding factor in the nonclinical assessment of GLP-1-based therapiesKristina D Chadwick, Anthony M Fletcher, M Cecilia Parrula, et al.
Pageof 93

Showing results (631-640 of 929) with videos related to

Sort By:
Pageof 93
International Journal of Toxicology|October 8, 2013
Nonclinical toxicology assessments support the chronic safety of dapagliflozin, a first-in-class sodium-glucose cotransporter 2 inhibitorMark Tirmenstein, Thomas E Dorr, Evan B Janovitz, et al.
Circulation|June 3, 1997
8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivoN Delanty, M P Reilly, D Pratico, et al.
Fertility and Sterility|March 16, 2010
Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trialShrita M Patel, Nayyar Iqbal, Shailja Kaul, et al.
Transfusion|July 1, 1997
The presurgical management with erythrocytapheresis of a patient with a high-oxygen-affinity, unstable Hb variant (Hb Bryn Mawr)P J Larson, D F Friedman, M P Reilly, et al.
Clinical Endocrinology|August 20, 2008
Resistin gene variation is associated with systemic inflammation but not plasma adipokine levels, metabolic syndrome or coronary atherosclerosis in nondiabetic CaucasiansAtif N Qasim, Thomas S Metkus, Mahlet Tadesse, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 30, 2014
Carcinogenicity risk assessment supports the chronic safety of dapagliflozin, an inhibitor of sodium-glucose co-transporter 2, in the treatment of type 2 diabetes mellitusTimothy P Reilly, Michael J Graziano, Evan B Janovitz, et al.
Clinical Endocrinology|September 30, 2010
Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetesAtif N Qasim, Venkata Budharaju, Nehal N Mehta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse modelS E McKenzie, S M Taylor, P Malladi, et al.
Ochsner Journal|September 24, 2016
Using the Minimally Invasive Impella 5.0 via the Right Subclavian Artery Cutdown for Acute on Chronic Decompensated Heart Failure as a Bridge to DecisionAditya Bansal, Jay K Bhama, Rajan Patel, et al.
Diabetes|November 14, 2013
Occurrence of spontaneous pancreatic lesions in normal and diabetic rats: a potential confounding factor in the nonclinical assessment of GLP-1-based therapiesKristina D Chadwick, Anthony M Fletcher, M Cecilia Parrula, et al.
Pageof 93